Zhejiang Medicine Co., Ltd. (SHA: 600216)

Zhejiang Medicine Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,469	1,460	1,438	1,769	1,629	1,278
Short-Term Investments	-	-	-	2.9	50	151.35
Trading Asset Securities	355.89	328.31	447.29	454.4	270.73	328.63
Cash & Short-Term Investments	1,825	1,788	1,885	2,226	1,950	1,758
Cash Growth	-4.76%	-5.15%	-15.30%	14.17%	10.91%	0.12%
Accounts Receivable	1,654	1,419	1,501	1,594	1,402	1,606
Other Receivables	97.76	239.14	67.35	105.17	141.38	94.05
Receivables	1,752	1,658	1,568	1,699	1,544	1,700
Inventory	1,907	2,011	1,995	1,873	1,480	1,435
Prepaid Expenses	-	-	0.03	0.36	0.9	3
Other Current Assets	186.31	143.88	207.17	236.04	143.85	143.77
Total Current Assets	5,670	5,601	5,655	6,035	5,118	5,039
Property, Plant & Equipment	6,094	6,019	5,618	5,360	4,513	4,459
Long-Term Investments	154.08	166.21	144.51	126.07	195.48	209.13
Goodwill	18.68	18.68	27.91	36.03	-	-
Other Intangible Assets	709.42	744.3	747.68	728.81	409.75	406.89
Long-Term Deferred Tax Assets	78.99	82.12	77.41	78.8	86.49	77.39
Long-Term Deferred Charges	4.92	6.22	8.85	0.41	27.18	28.26
Other Long-Term Assets	148.01	141.15	153.27	167.76	150.18	142.39
Total Assets	12,878	12,780	12,433	12,532	10,500	10,362
Accounts Payable	1,117	744.03	702.48	897.83	504.75	637.39
Accrued Expenses	100.63	253.95	263.98	287.32	534.42	433.24
Short-Term Debt	235.23	231.41	82.25	225.33	250.31	649.98
Current Portion of Long-Term Debt	141.45	370.37	550.64	-	200.17	-
Current Portion of Leases	-	0.3	0.28	-	-	-
Current Income Taxes Payable	73.37	11.88	21.75	153.51	95.69	46.41
Current Unearned Revenue	43.47	43.95	61.88	53.81	54.6	51.52
Other Current Liabilities	419.07	822.53	782.11	1,407	284.22	232.03
Total Current Liabilities	2,130	2,478	2,465	3,025	1,924	2,051
Long-Term Debt	424.36	230.22	200.19	250.34	500.65	-
Long-Term Leases	0.16	0.32	0.62	1.16	-	-
Long-Term Unearned Revenue	78.78	84.16	54.11	53.08	34.24	36.56
Long-Term Deferred Tax Liabilities	-	-	2.47	21.12	11.38	23.02
Total Liabilities	2,633	2,793	2,723	3,350	2,470	2,110
Common Stock	961.64	964.98	965.13	965.13	965.13	965.13
Additional Paid-In Capital	1,986	2,005	1,941	1,692	1,398	1,343
Retained Earnings	6,998	6,682	6,417	6,195	5,371	5,611
Treasury Stock	-	-27.63	-57.69	-59.98	-59.98	-59.98
Comprensive Income & Other	1.78	5.77	-5.27	-13.99	0.41	1.4
Total Common Equity	9,947	9,631	9,260	8,779	7,675	7,861
Minority Interest	297.78	355.68	449.98	402.93	355.48	391.39
Shareholders' Equity	10,245	9,986	9,710	9,182	8,030	8,252
Total Liabilities & Equity	12,878	12,780	12,433	12,532	10,500	10,362
Total Debt	801.2	832.63	833.97	476.82	951.12	649.98
Net Cash (Debt)	1,024	955.7	1,051	1,749	998.53	1,108
Net Cash Growth	-7.49%	-9.10%	-39.89%	75.16%	-9.87%	-12.12%
Net Cash Per Share	1.07	0.99	1.09	1.82	1.04	1.16
Filing Date Shares Outstanding	914.29	925.92	958.3	958.3	958.3	958.3
Total Common Shares Outstanding	914.29	925.92	958.3	958.3	958.3	958.3
Working Capital	3,540	3,123	3,190	3,010	3,194	2,989
Book Value Per Share	10.88	10.40	9.66	9.16	8.01	8.20
Tangible Book Value	9,219	8,868	8,484	8,014	7,265	7,454
Tangible Book Value Per Share	10.08	9.58	8.85	8.36	7.58	7.78
Buildings	-	2,919	2,812	2,509	2,171	2,031
Machinery	-	6,897	6,158	5,366	4,839	4,692
Construction In Progress	-	931.69	825.71	1,119	638.83	466.84

Source: S&P Capital IQ. Standard template. Financial Sources.